Literature DB >> 3144458

Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen.

J L Maryanski1, P Pala, J C Cerottini, H R MacDonald.   

Abstract

While it is generally agreed that the specificity of the interaction between cytolytic T lymphocytes (CTL) and their target cells is controlled mainly by antigen-specific T cell receptors (TcR), the molecular role of cell surface CD8 molecules in this interaction is less well understood. In the present study we have reinvestigated the apparent contribution of CD8 molecules to the overall avidity of interaction between CTL and their targets by using a recently developed system of major histocompatibility complex (MHC) class I-restricted CTL clones that recognize defined peptide antigens. We demonstrate that under conditions where the density of MHC, TcR and accessory molecules remains constant, the susceptibility of CD8+ CTL to inhibition of cytolysis by anti-CD8 antibodies is highly dependent upon the concentration and primary structure of the peptide antigen. Although the precise role of the CD8 molecule remains unknown, our results are compatible with models that suggest its contribution to the overall avidity of the CTL-target cell interaction particularly in cases where the affinity between the TcR and antigen-MHC is low.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144458     DOI: 10.1002/eji.1830181135

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  A signaling role for the cytoplasmic segment of the CD8 alpha chain detected under limiting stimulatory conditions.

Authors:  F Letourneur; J Gabert; P Cosson; D Blanc; J Davoust; B Malissen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Authors:  M A Alexander-Miller; G R Leggatt; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

3.  Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein--long form-transgenic mice.

Authors:  Sally Huber; Austin Dohrman; Danielle Sartini; Ralph C Budd
Journal:  Immunology       Date:  2006-09-28       Impact factor: 7.397

4.  Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation.

Authors:  G Stuber; F Vánky; E Pócsik; M Benczúr; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Resting and activated T cells display different requirements for CD8 molecules.

Authors:  Z Cai; J Sprent
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

6.  Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene.

Authors:  F Lehmann-Grube; J Löhler; O Utermöhlen; C Gegin
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Identification of the promoter of the mouse obese gene.

Authors:  F C de la Brousse; B Shan; J L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

8.  Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.

Authors:  F Vánky; P Wang; M Patarroyo; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro.

Authors:  Z Cai; J Sprent
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.